Location History:
- Brussels, BE (2011)
- Ganshoren, BE (2012 - 2014)
Company Filing History:
Years Active: 2011-2014
Title: The Innovative Contributions of Gregory Thoorens
Introduction
Gregory Thoorens, a talented inventor based in Ganshoren, Belgium, has made significant strides in the field of pharmaceutical excipients. With a total of four patents to his name, Thoorens is recognized for his innovative approaches to enhancing the performance of solid dosage forms used in pharmaceuticals.
Latest Patents
Among Gregory Thoorens' latest patents are two noteworthy innovations that focus on microcrystalline cellulose and calcium phosphate compositions. The first patent describes compositions that serve as pharmaceutical excipients. These compositions incorporate calcium phosphate with a small median particle size, which enhances the recompactibility of solid dosage forms involving multiple compaction steps. The second patent delves into co-processed compositions containing microcrystalline cellulose and calcium carbonate. The high weight ratio of microcrystalline cellulose to calcium carbonate in these compositions improves their use as excipients, particularly in solid dosage preparations. These developments showcase Thoorens' commitment to advancing pharmaceutical technology through effective and versatile excipients.
Career Highlights
Currently, Gregory Thoorens is affiliated with Fmc Corporation, a leading entity in the field of specialty chemicals. His work involves collaboration on various research projects aimed at refining the formulation and efficacy of pharmaceutical products. Thoorens' innovative contributions have played a crucial role in enabling better drug delivery systems.
Collaborations
Throughout his career, Gregory has had the opportunity to collaborate with esteemed colleagues, including Bruno LeClercq and Thomas A Ruszkay. These partnerships have fostered a dynamic working environment that promotes the exchange of ideas and drives innovative developments in the pharmaceutical industry.
Conclusion
Gregory Thoorens has established himself as a prominent figure in the realm of pharmaceutical excipients. His innovative patents reflect a commitment to enhancing the quality and efficacy of solid dosage forms. As he continues to collaborate with his team at Fmc Corporation, the potential for further advancements in this field remains promising.